HealthCureVac Only 47% Effective, Fails COVID-19 Vaccine Trial CureVac fails a crucial COVID-19 vaccine trial after a late-stage study showed that its efficacy is only at 47%by Isabella James
ScienceGerman Astronaut Shares Photos of Space Food in an Experiment to Better Understand the Bodyby Urian B.
HealthChina COVID-19 Vaccine May Not 'Last for 6 Months' | Health Experts Suggest People Get a 3rd Doseby Urian B.
HealthIbuprofen Does Not Intensify Covid-19, Study Confirms -- When Does it Become Harmful?by Teejay Boris
HealthNo Vaccine No Entry | Over 100 US Colleges & Universities Require Students to Get Vaccinatedby Urian B.
HealthModerna COVID-19 Booster: New Shots Bring Better Protection Against Variants like South Africa, Brazil Strainsby Isaiah Richard
HealthPfizer CEO Says COVID-19 Oral Pill Could Arrive At the End of 2021- Powerful Enough to Create 'End-to-End' Treatment Paradigm?by Joseph Henry
HealthUS to Gain Leverage on Big Pharma-- Scientist, Developer of Pfizer’s Key Vaccine Tech Says His Reason Behind Joining NIHby Gabrielle N.
Health'Adenovirus' Ingredient on J&J, AstraZeneca's COVID-19 Vaccines—Why Do They Cause Alarm?by Isaiah Alonzo
HealthJohnson & Johnson's COVID-19 Vaccine Delays Due to Reported Human Error's Wrong Ingredientby Lionell Moore